News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Insights
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Insights
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
Search Query
Submit Search
News
FDA
Novo Nordisk A/S’s Novoeight Wins FDA Approval for Hemophilia A
October 16, 2013
|
1 min read
Twitter
LinkedIn
Facebook
Email
Print
Denmark's Novo Nordisk has received a licence application approval in the United States for its haemophilia drug Novoeight.
Help employers find you! Check out all the
jobs
and
post your resume
.
Twitter
LinkedIn
Facebook
Email
Print
FDA
Approvals
Europe
Novo
MORE ON THIS TOPIC
Podcast
Q3 earnings roll on, FDA pushes rare disease, uniQure’s Huntington’s therapy reaches review
November 4, 2026
·
1 min read
·
Jef Akst
Psychedelics
Compass to submit psilocybin depression drug for approval imminently after stock wobbles
November 3, 2026
·
2 min read
·
Heather McKenzie
FDA
UniQure snags May Day decision date for Huntington’s gene therapy after arduous year
November 2, 2026
·
2 min read
·
Heather McKenzie
FDA
Plug-and-play gene therapy: FDA executes on vision that’s been in the works for years
November 2, 2026
·
6 min read
·
Heather McKenzie